{"a": [["Atorvastatin in factorial with omega\u20103 risk reduction in diabetes) (Abstract) Register for Randomised Controlled Trials", "2004"], ["Oxford Clinical Trials Service Unit", "2005"], ["Background and rationale of the SU.FO.LOM3 study: double blind placebo\u2010controlled secondary prevention trial to test the impact with supplementation with folate, vitamin B6 and B12 and/or omega\u20103 fatty acids on the prevention of recurrent ischemic events in subjects with artherosclerosis in the coronary or cerebral arteries", "2003"], ["Outcome Reduction with Initial Glargine Intervention (Abstract) Clinical Trials.gov Identifier: NCT00069784", "2005"], ["Management of Dyslipidemia in Adults with Diabetes. Diabetes Care", "1998"], ["Effects of omega\u20103 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease. Prepared by Tufts New England Medical Center Evidence\u2010based Practice Center, Rockville, MD.", "2004"], ["The composition of food consumed by Greenland Eskimos", "1976"], ["N\u20103 polyunsaturated fatty acids in coronary heart disease: a meta\u2010analysis of radomized controlled trials", "2002"], ["Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART)", "1999"], ["Lack of benefit of dietary advice to men with angina: results of a controlled trial", "2003"], ["Importance of n\u20103 fatty acids in health and disease", "2000"], ["Identifying relevant studies for systematic reviews", "1994"], ["Bias in meta\u2010analysis detected by a simple, graphical test", "1997"], ["Cardiovascular outcomes in type 2 diabetes: a double blind placebo\u2010controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Prevention (SENDCAP) Study", "1998"], ["Fish oin in people with type 2 diabetes", "2001"], ["Fish oil supplementation versus gemfibrozil treatment in hyperlipidemic NIDDM: a randomized crossover study", "1996"], ["Apolipoprotein B metabolism in hypertriglyceridemic patients administered either a fish oil\u2010 or vegetable oil\u2010enriched diet", "1998"], ["Elevated plasma glucose and lowered triglyceride levels from omega\u20103 fatty acid supplementation in type II diabetes", "1989"], ["Nicotinic acid as therapy for dyslipidaemia in non\u2010insulin dependent diabetes mellitus", "1990"], ["Dietary supplementation with n\u20103 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI\u2010Prevenzione trial", "1999"], ["Adverse metabolic effect of omega\u20103 fatty acids in non\u2010insulin dependent diabetes mellitus", "1988"], ["Omega\u20103 fatty acids for prevention and treatment of cardiovascular disease", "2004"], ["Lipoprotein metabolism in diabetes mellitus", "1987"], ["Assessing the quality of reports of randomized clinical trials: is blinding necessary?", "1996"], ["Normal reference laboratory values", "1998"], ["Low density lipoprotein from humans supplemented with n\u20103 fatty acids depresses both LDL receptor activity and LDLr mRNA abundance in HepG2 cells", "1992"], ["Apo E polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype", "2000"], ["Fish oil supplementation in type 2 diabetes", "2000"], ["Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men", "2000"], ["Diabetes mellitus in eskimos", "1967"], ["Comparison of percent total GHb with percent HbA1c in people with and without known diabetes", "1998"], ["Effect of n\u20103f fatty acids on metabolism of apoB100\u2010containing lipoproteins in type 2 diabetic subjects", "2006"], ["Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a sub\u2010group analysis of the Scandinavian Simvastatin Survival Study", "1997"], ["Mathematical Statistics and Data Analysis", "1995"], ["Dietary fish oil decreases low\u2010density\u2010lipoprotein clearance in non\u2010human primates", "1996"], ["Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials", "1995"], ["Dependence on dietary cholesterol for n\u20103 polyunsaturated fatty acid\u2010induced changes in plasma cholesterol in the Syrian hamster", "1992"], ["Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages", "1995"], ["LDL cholesterol\u2010raising effect of low\u2010dose docosahexaenoic acid in middle\u2010aged men and women", "2004"], ["Impact of covert duplicate publication on meta\u2010analysis: a case study", "1997"]], "ex": [["Lower prevalence of impaired glucose tolerance and diabetes associated with daily seal oil or salmon consumption among Alaska Natives", "1994"], ["Supplementation with olive oil rather than fish oil increases small arterial compliance in diabetic patients", "1995"], ["Lipid peroxides and essential fatty acids in patients with diabetes mellitus and diabetic nephropathy", "1994"], ["Essential fatty acid metabolism in south Indians", "1994"], ["Essential fatty acid metabolism in patients with hypertension, diabetes mellitus and coronary heart disease", "1995"], ["The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomized controlled study", "1997"], ["Long\u2010term effects of n\u20103 fatty acids on serum lipids and glycaemic control", "1994"], ["Metabolic effects of fish\u2010oil supplementation in patients with impaired glucose tolerance", "1991"], ["Fish oil and glycemic control in diabetes: A meta\u2010analysis", "1998"], ["Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester", "1990"], ["Effect of fish oil concentrate on the lipoprotein profile of patients with type II diabetes mellitus", "1992"], ["Eicosanoid precursors: potential factors for atherogenesis in diabetic CAPD patients?", "1996"], ["Is it time for a clinical trial of dietary fish oil supplementation in individuals with NIDDM?", "1993"], ["Effects of omega\u20103 fish oils on lipid metabolism, glycemic control and blood pressure in type II diabetic patients", "1988"], ["Fish oil, essential fatty acids, and hypertension", "1994"], ["Evaluation of an omega\u20103 fatty acid supplement in diabetics with microalbuminuria", "1997"], ["Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia", "1994"], ["Biological effects of omega\u20103 fatty acids in diabetes mellit", "1991"], ["Fish consumption and cardiovascular disease in the physicians' health study: a prospective study", "1995"], ["Beneficial effects of eicosapentaenoic acid for diabetic patients with arteriosclerosis obliterans [1]", "1992"], ["Long term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus", "1996"], ["Do n\u20103 fatty acids improve glucose tolerance and lipaemia in diabetics", "1997"], ["Fish oil in diabetic nephropathy", "1996"], ["The effects of short\u2010term omega\u20103 polyunsaturated fatty acid supplementation in patients with chronic renal insufficiency", "1991"], ["Fish oils and their possible role in the treatment of cardiovascular disorders", "1994"], ["Effects of high fiber intake in fish\u2010oil treated patients with non\u2010insulin\u2010dependent diabetes mellitus", "1997"], ["Effect of eicosapentaenoic acid ethyl on urine albumin excretion in NIDDM", "1993"], ["Long term effect of eicosapentaenoic acid ethyl (EPA\u2010E) on albuminuria of non\u2010insulin dependent diabetic patients", "1995"], ["Effects of eicosapentaenoic acid on glycemic control and lipid metabolism in healthy and NIDDM subjects", "1992"], ["The triglyceride lowering effect of fish oils is affected by fish consumption", "1996"], ["One year treatment with ethyl\u2010esthers of n\u20103 fatty acids in patients with hypertriglyceridemia and glucose intolerance reduced triglyceridemia, total cholessterol and increased HDL\u2010C without glycemic alterations", "1998"], ["Dose response effects of dietary marine oil on carbohydrate and lipid metabolism in normal subjects and patients with hypertriglyceridemia", "1989"], ["Experience with fish oil treatment with special emphasis on diabetic nephropathy", "1990"], ["Drug therapy of hyperlipidaemia \u2010 unanswered questions", "1997"], ["Vitamin E and the susceptibility of erythrocytes and reconstituted liposomes to oxidative stress in aged diabetics", "1991"], ["Effect of eicosapentaenoic acid and docosahexaenoic acid on diabetic osteopenia", "1995"], ["Effects of fish oils in patients with type 2 diabetes with associated dyslipidaemia", "1996"], ["Effects of glyburide and omega 3 fatty acid dietary supplements on glucose and lipid metabolism in patients with non insulin dependent diabetes mellitus", "1992"]], "in": [["Effects of diet therapy including eiconol on clinical and metabolic parameters in patients with type 2 diabetes mellitus", "2000"], ["A controlled study on the effects of n\u20103 fatty acids on lipid and glucose metabolism in non\u2010insulin\u2010dependent diabetic patients", "1991"], ["Effects of a small quantity of omega\u20103 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double\u2010blind, controlled study", "1994"], ["Supplementation with n\u20103 fatty acids reduces triglycerides but increases PAI\u20101 in non\u2010insulin\u2010dependent diabetes mellitus", "1992"], ["Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM", "1989"], ["The hypotriglyceridemic effect of fish oil in adult\u2010onset diabetes without adverse glucose control", "1993"], ["Effect of omega 3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients", "1997"], ["Effects of fish oil supplements in NIDDM subjects. Controlled study", "1990"], ["Effects of low\u2010dose omega\u20103 fatty acid substitution in type\u20102 diabetes mellitus with special reference to oxidative stress\u2010\u2010a prospective preliminary study", "2002"], ["Moderate intake of n\u20103 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study", "1998"], ["Effect of dietary fish oil supplementation on peroxidation of serum lipids in patients with non\u2010insulin dependent diabetes mellitus", "1996"], ["A comparison of the effects of n\u20103 fatty acids from linseed oil and fish oil in well\u2010controlled type II diabetes", "1996"], ["A comparison of fish oil or corn oil supplements in hyperlipidemic subjects with NIDDM", "1995"], ["Effects of n\u20103 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time\u2010dependent alteration from carbohydrate to fat oxidation [published erratum appears in The American journal of clinical nutrition 2007;85(6):1668]", "2006"], ["Metabolic effects of omega\u20103 fatty acids in type 2 (non\u2010insulin\u2010dependent) diabetic patients", "1993"], ["Influence of fish oil supplementation on in vivo and in vitro oxidation resistance of low\u2010density lipoprotein in type 2 diabetes", "2003"], ["Dietary supplementation with n\u20103 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non\u2010insulin\u2010dependent diabetes mellitus", "1995"], ["Effect of fish oil concentrate on lipoprotein composition in NIDDM", "1988"], ["Metabolic and Haemostatic Consequences of Dietary Fibre and N\u20103 Fatty Acids in Black Type 2 (NIDDM) Diabetic Subjects: A Placebo Controlled Study", "1990"], ["Long\u2010term effects (six months) of omega\u20103 polyunsaturated fatty acids on insulin sensitivity and lipid metabolism in patients with type 2 diabetes and hypertriglycaeridemia", "1996"], ["Dietary supplementation with n\u20103 fatty acids may impair glucose homeostasis in patients with non\u2010insulin\u2010dependent diabetes mellitus", "1990"], ["Effects of low\u2010dose EPA\u2010E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM", "1993"], ["Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated\u2010hypertensive type 2 diabetic subjects", "2003"]]}